Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1953 2
1956 2
1957 1
1962 1
1965 2
1966 1
1967 2
1971 1
1973 1
1975 1
1976 1
1977 2
1978 1
1979 4
1980 2
1981 1
1982 6
1983 8
1984 3
1985 2
1986 1
1987 6
1988 5
1989 2
1990 1
1991 6
1992 4
1993 2
1994 4
1995 2
1996 4
1997 4
1998 2
1999 3
2000 3
2001 4
2002 8
2003 6
2004 2
2005 6
2006 5
2007 4
2008 11
2009 11
2010 9
2011 13
2012 5
2013 11
2014 4
2015 20
2016 15
2017 10
2018 4
2019 17
2020 21
2021 22
2022 16
2023 29
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Results by year

Filters applied: . Clear all
Page 1
Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition.
Pasciuto E, Burton OT, Roca CP, Lagou V, Rajan WD, Theys T, Mancuso R, Tito RY, Kouser L, Callaerts-Vegh Z, de la Fuente AG, Prezzemolo T, Mascali LG, Brajic A, Whyte CE, Yshii L, Martinez-Muriana A, Naughton M, Young A, Moudra A, Lemaitre P, Poovathingal S, Raes J, De Strooper B, Fitzgerald DC, Dooley J, Liston A. Pasciuto E, et al. Among authors: de la fuente ag. Cell. 2020 Aug 6;182(3):625-640.e24. doi: 10.1016/j.cell.2020.06.026. Epub 2020 Jul 22. Cell. 2020. PMID: 32702313 Free PMC article.
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Giné E, de la Cruz F, Jiménez Ubieto A, López Jimenez J, Martín García-Sancho A, Terol MJ, González Barca E, Casanova M, de la Fuente A, Marín-Niebla A, Muntañola A, González-López TJ, Aymerich M, Setoain X, Cortés-Romera M, Rotger A, Rodríguez S, Medina Herrera A, García Sanz R, Nadeu F, Beà S, Campo E, López-Guillermo A. Giné E, et al. Among authors: de la fuente a. J Clin Oncol. 2022 Apr 10;40(11):1196-1205. doi: 10.1200/JCO.21.02321. Epub 2022 Jan 14. J Clin Oncol. 2022. PMID: 35030036 Free PMC article. Clinical Trial.
Novel therapeutic approaches to target neurodegeneration.
de la Fuente AG, Pelucchi S, Mertens J, Di Luca M, Mauceri D, Marcello E. de la Fuente AG, et al. Br J Pharmacol. 2023 Jul;180(13):1651-1673. doi: 10.1111/bph.16078. Epub 2023 Apr 26. Br J Pharmacol. 2023. PMID: 36965025 Free article. Review.
Glial cell alterations in diabetes-induced neurodegeneration.
Llorián-Salvador M, Cabeza-Fernández S, Gomez-Sanchez JA, de la Fuente AG. Llorián-Salvador M, et al. Among authors: de la fuente ag. Cell Mol Life Sci. 2024 Jan 18;81(1):47. doi: 10.1007/s00018-023-05024-y. Cell Mol Life Sci. 2024. PMID: 38236305 Free PMC article. Review.
Autoantibodies and microglia: boon or bane?
Naughton M, de la Fuente AG. Naughton M, et al. Among authors: de la fuente ag. Brain. 2021 Sep 4;144(8):2231-2233. doi: 10.1093/brain/awab269. Brain. 2021. PMID: 34382068 No abstract available.
Systematic Review on the Creep of Fiber-Reinforced Concrete.
Tošić N, Aidarov S, de la Fuente A. Tošić N, et al. Among authors: de la fuente a. Materials (Basel). 2020 Nov 12;13(22):5098. doi: 10.3390/ma13225098. Materials (Basel). 2020. PMID: 33198156 Free PMC article. Review.
325 results